Harbor Healthcare announces home infusion deal
By HME News Staff
Updated 10:31 AM CST, Mon January 24, 2022
SAN DIEGO – Harbor Healthcare has announced the successful sale of a California-based home infusion pharmacy to a strategic buyer that maintains a nationwide presence in the home infusion space. The acquisition provides the buyer with key access to a competitive market, according to Harbor Healthcare, a boutique investment bank offering a variety of M&A advisory services to middle market health care and pharmacy businesses. "Joining a legacy pharmacy with a management team that brings decades of experience in the space is an exceptional opportunity,” said Michael Cammeyer, managing director of Harbor Healthcare. “With the expanded customer facing team, the newly formed business is in an ideal position to service patients while expanding its geographical footprint. We are excited to watch this pharmacy grow from the synergies created by this investment.” The buyer specializes in intravenous immunoglobin (IVIG), total parenteral nutrition (TPN) and other specialty infusion products.
Comments